Washington University opens clinic for treatment-resistant depression

Washington University School of Medicine has opened a clinic for patients with treatment-resistant depression that targets those who haven’t responded to standard therapies. When at least two therapies have been tried, and a patient still hasn’t responded, that patient is said to have treatment-resistant depression, according to clinic director Charles R. Conway, MD.  

How green is your science lab? Olin competition looks for sustainable solutions

Try to imagine an environmentally friendly science lab that reduces, reuses and recycles. That’s the challenge posed by the second annual Olin Sustainability Case Competition at Washington University in St. Louis. Students who devise the best plan for green labs will be seeing green — a $5,000 first prize — when the winners are announced in February.

Brain scans show effects of Parkinson’s drug

Neuroscientists using a new brain imaging technique could see an investigational drug for Parkinson’s disease get into a patient’s brain and affect blood flow in several key structures, an indicator the drug may be effective. In the future, similar brain scans could speed the development of new drugs and help clinicians learn whether established drugs are working.  

CT screening reduces lung-cancer deaths in heavy smokers

In a study of heavy smokers, fewer screened with low-dose CT scans died, compared with similar smokers screened with standard chest X-rays. The National Cancer Institute ran the 33-center National Lung Screening Trial to learn whether more sensitive screening could have an impact on lung-cancer deaths, and Washington University researchers involved in the study say it did.
Older Stories